|
Volumn 11, Issue 5, 2003, Pages 651-654
|
Requirement of drug development for chronic renal disease: Other strategies than blockade of the renin-angiotensin system.
a |
Author keywords
[No Author keywords available]
|
Indexed keywords
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
IMMUNOSUPPRESSIVE AGENT;
CHRONIC KIDNEY FAILURE;
DRUG DESIGN;
DRUG EFFECT;
HUMAN;
PATHOPHYSIOLOGY;
RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;
REVIEW;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
DRUG DESIGN;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY FAILURE, CHRONIC;
RENIN-ANGIOTENSIN SYSTEM;
|
EID: 0642378276
PISSN: 11073756
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (2)
|
References (44)
|